Cargando…
METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Methyltransferase-like 7B (METTL7B) is a member of the methyltransferase-like protein family that plays an important role in the development and progression of tumors. However, its prognostic value and the correlation of METTL7B expression and tumor immunity in some cancers remain unclear. By analyz...
Autores principales: | Jiang, Zhipeng, Yin, Wen, Zhu, Hecheng, Tan, Jun, Guo, Youwei, Xin, Zhaoqi, Zhou, Quanwei, Cao, Yudong, Wu, Zhaoping, Kuang, Yirui, Li, Can, Xie, Dongcheng, Huang, Hailong, Zhao, Ming, Jiang, Xingjun, Wang, Lei, Ren, Caiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287669/ https://www.ncbi.nlm.nih.gov/pubmed/34281539 http://dx.doi.org/10.1186/s12935-021-02087-4 |
Ejemplares similares
-
Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021) -
Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021) -
Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022) -
Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020) -
Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
por: Cao, Yudong, et al.
Publicado: (2022)